The year 2024 was a transformative period for digital health, marked by significant advancements, setbacks, and controversies. The NHS and the broader health tech landscape experienced a series of pivotal events that shaped the future of healthcare. This article delves into the top stories that
The current landscape of healthcare access in the United States faces significant challenges, particularly in the realm of medical imaging for patients covered by Medicaid. Radiology experts have long emphasized that the reimbursement rates for Medicaid are strikingly lower compared to those of
The recent legislative and regulatory changes in telehealth have introduced significant updates that impact both healthcare providers and patients. These modifications aim to extend the flexibilities originally introduced during the COVID-19 public health emergency (PHE), ensuring the continued
The global AI in medical imaging market is set to witness unprecedented growth, expected to surge from $2.80 billion in 2023 to an astounding $29.28 billion by 2029. This extraordinary expansion, indicating a CAGR of 47.84% over six years, underscores the transformative impact that artificial
As 2024 draws to a close, the impending expiration of telehealth flexibilities looms, potentially reversing transformative changes made during the COVID-19 pandemic. These adjustments significantly expanded telehealth capabilities, especially within the Medicare system, and their lapse could result
Intellia Therapeutics (NASDAQ: NTLA) is a prominent player in the genome editing industry with a market capitalization of $1.3 billion. The company's groundbreaking work in leveraging CRISPR/Cas9 technology is pushing the boundaries of genetic medicine. Even though Intellia has faced
